Exact Sciences
EXAS
#1783
Rank
S$12.42 B
Marketcap
$67.13
Share price
-2.28%
Change (1 day)
-16.72%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2023 (TTM): -$2.13

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is -$2.12. In 2022 the company made an earnings per share (EPS) of -$4.74 a decrease over its 2021 EPS that were of -$4.63.

EPS history for Exact Sciences from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.13-55.1%
2022-$4.742.31%
2021-$4.63-37.09%
2020-$7.36674.65%
2019-$0.95-50.69%
2018-$1.9344%
2017-$1.34-39.39%
2016-$2.21-2.94%
2015-$2.2737.1%
2014-$1.6679.71%
2013-$0.92-21.59%
2012-$1.1862.96%
2011-$0.7292.86%
2010-$0.37-3.45%
2009-$0.39-19.44%
2008-$0.48-18.18%
2007-$0.59-10.2%
2006-$0.66-10.91%
2005-$0.74-24.66%
2004-$0.98-51.33%
2003-$2.01-7.41%
2002-$2.1711.72%
2001-$1.94

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$4.07 91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.45-121.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.54-74.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-$68.12 3,110.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.26-300.57%๐Ÿ‡ซ๐Ÿ‡ท France